Controlled Release of Oxycodone 10 mg In Pre-Medication For The Post Operative Analgesia In Elective Laparoscopic Bilateral Inguinal Hernia And Elective Laparoscopic Cholecystectomy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00480142|
Recruitment Status : Unknown
Verified May 2007 by Kaplan Medical Center.
Recruitment status was: Not yet recruiting
First Posted : May 30, 2007
Last Update Posted : June 6, 2007
A Prospective Double Blind RCT: Controlled Release Oxycodone 10 mg On a 12 h Dosing Schedule Started With The Premedication ,Placebo Controlled Study,On Post Operative Analgesia Management in Laparoscopic Cholecystectomy and Laparoscopic Bilateral Inguinal Hernia (BIH).
CRO is indicated for the management of moderate to severe pain when a continuous,around the clock analgesic is needed for an extended period of time.Its safety and efficacy in the first 12-24 hours post operative has not been established.
|Condition or disease||Intervention/treatment||Phase|
|Elective Laproscopic Bilateral Inguinal Hernia Elective Laproscopic Cholecystectomy||Drug: Oxycodone 10 mg||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Controlled Release of Oxycodone 10 mg In Pre-Medication For The Post Operative Analgesia In Elective Laparoscopic Bilateral Inguinal Hernia And Elective Laparoscopic Cholecystectomy : Prospective Double Blind, Randomized, Placebo-Controlled Study|
|Study Start Date :||July 2007|
|Study Completion Date :||July 2008|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00480142
|Contact: Oscar Liphshitz, MDemail@example.com|
|Principal Investigator:||patricia grosman, MD||Israel: Kaplan Hospital, Clalit Health Service|
|Study Chair:||Eli Mavor, MD||Israel:Clalit Health Service|
|Study Director:||oscar liphshitz, MD||Isreal: Kaplan: Clalit Health Service|
|Study Director:||Bella Almog, R.N MA||Israel: Kaplan: Clalit Health Service|